Latest Hepatitis C/co-infection with HIV Stories
According to the CDC, Hepatitis C is the most common chronic blood borne infection in the United States affecting more than 3.2 million people.
Response-guided treatment with drug telaprevir can be shortened to 6 months for many.
University of Cincinnati research published in the Sept. 14, 2011, advance online edition of the New England Journal of Medicine shows that patients with hepatitis C who took a combination medication—a telaprevir-based regimen that is commonly used to treat the illness—for 24 weeks were cured.
A new multinational study finds that a 24-week treatment course for hepatitis C that adds telaprevir to peginterferon alfa and ribavirin is just as effective as a 48-week regimen for many patients.
Genotyping hepatitis C patients significantly improves doctors’ ability to predict whether or not patients will respond to antiviral treatment.
Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...
- To swell, as grain or wood with water.